Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04622163 · ClinicalTrials.gov registry record · NA

Secondary Mentoring Program Evaluation

A NA study of Satisfaction, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04622163 is a NA study of Satisfaction that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants, below the 129-participant average among 6 other Satisfaction trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04622163, a NA study of Satisfaction, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Mentorship is essential to job satisfaction and promotion among academic physicians, and literature suggests that a single mentor is rarely sufficient. The investigators are studying whether implementation of a secondary mentorship program among physicians at their institution leads to improved job satisfaction over 6 months.

Conditions Studied

Interventions

  • OTHER Secondary Mentor
  • OTHER Career Development Resources

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-01-04
Est. Completion 2022-02-03
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04622163

The ClinicalTrials.gov registry entry for NCT04622163 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 129-participant average among 6 other Satisfaction trials with a reported enrollment target (69% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Satisfaction appearing as the primary indexed condition, and to 2 interventions - of which Secondary Mentor is the first listed.

NCT04622163 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04622163 about?

NCT04622163 is a clinical study titled "Secondary Mentoring Program Evaluation". Mentorship is essential to job satisfaction and promotion among academic physicians, and literature suggests that a single mentor is rarely sufficient. The investigators are studying whether implementation of a secondary mentorship program among physicians at their institution leads to improved job ...

What is the current status of trial NCT04622163?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-01-04. Estimated completion is 2022-02-03.

What conditions does trial NCT04622163 study?

This clinical trial studies the following conditions: Satisfaction.

What interventions are being tested in trial NCT04622163?

The interventions under investigation include: Secondary Mentor (OTHER), Career Development Resources (OTHER).

Who is sponsoring clinical trial NCT04622163?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04622163 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Satisfaction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.